Pro Share Advisors LLC Ampio Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$0.16 - $0.47 $5,845 - $17,170	-36,533 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$0.42 - $0.62 $2,533 - $3,739	-6,032 Reduced 14.17%	36,533 $17,000
Q4 2021 Feb 08, 2022	BUY	$0.56 - $1.71 $9,854 - $30,092	17,598 Added 70.49%	42,565 $24,000
Q3 2021 Nov 12, 2021	SELL	$1.21 - $1.8 $29,499 - $43,884	-24,380 Reduced 49.41%	24,967 $41,000
Q2 2021 Aug 13, 2021	BUY	$1.56 - $1.98 $76,981 - $97,707	49,347 New	49,347 $82,000
Q3 2019 Nov 12, 2019	SELL	$0.38 - $0.52 $3,940 - $5,392	-10,371 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$0.39 - $0.7 $106 - $191	-274 Reduced 2.57%	10,371 $4,000
Q1 2019 May 15, 2019	BUY	$0.43 - $0.68 $142 - $225	332 Added 3.22%	10,645 $6,000
Q4 2018 Feb 14, 2019	SELL	$0.39 - $0.7 $648 - $1,164	-1,663 Reduced 13.89%	10,313 $4,000
Q3 2018 Nov 14, 2018	BUY	$0.44 - $3.02 $672 - $4,617	1,529 Added 14.64%	11,976 $6,000
Q2 2018 Aug 13, 2018	BUY	$1.66 - $3.82 $17,342 - $39,907	10,447 New	10,447 $23,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.